BSE - Delayed Quote INR
Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
1,744.85
-21.35
(-1.21%)
At close: May 9 at 3:29:35 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
510,390,000
477,584,500
432,788,700
384,264,200
332,330,800
Cost of Revenue
118,976,300
120,696,600
119,424,200
103,515,400
98,854,200
Gross Profit
391,413,700
356,887,900
313,364,500
280,748,800
233,476,600
Operating Expense
269,126,700
252,206,100
220,590,900
199,748,600
169,334,200
Operating Income
122,287,000
104,681,800
92,773,600
81,000,200
64,142,400
Net Non Operating Interest Income Expense
7,671,200
7,844,400
2,125,400
-1,273,500
700,400
Pretax Income
133,133,000
110,878,900
94,084,300
44,813,200
27,993,700
Tax Provision
18,272,500
14,394,500
8,475,900
10,755,000
5,146,900
Net Income Common Stockholders
114,337,400
95,763,800
84,735,800
32,727,300
29,038,200
Diluted NI Available to Com Stockholders
114,337,400
95,763,800
84,735,800
32,727,300
29,038,200
Basic EPS
47.70
39.90
35.30
13.60
12.10
Diluted EPS
47.70
39.90
35.30
13.60
12.10
Basic Average Shares
2,395,791.08
2,399,334.97
2,399,334.97
2,406,419.12
2,399,334.97
Diluted Average Shares
2,395,791.08
2,399,334.97
2,399,334.97
2,406,419.12
2,399,334.97
Rent Expense Supplemental
--
734,300
588,700
535,400
419,800
Total Expenses
388,103,000
372,902,700
340,015,100
303,264,000
268,188,400
Net Income from Continuing & Discontinued Operation
114,337,400
95,763,800
84,735,800
32,727,300
29,038,200
Normalized Income
117,220,192.96
99,337,186.72
86,386,834.68
67,435,683.21
61,957,564.60
Interest Income
--
10,229,100
3,845,400
5,533,700
2,111,300
Interest Expense
2,557,900
2,384,700
1,720,000
1,273,500
1,410,900
Net Interest Income
7,671,200
7,844,400
2,125,400
-1,273,500
700,400
EBIT
135,690,900
113,263,600
95,804,300
46,086,700
29,404,600
EBITDA
161,310,500
138,831,500
121,108,600
67,524,100
50,204,100
Reconciled Cost of Revenue
118,976,300
120,696,600
119,424,200
103,515,400
98,854,200
Reconciled Depreciation
25,619,600
25,567,900
25,304,300
21,437,400
20,799,500
Net Income from Continuing Operation Net Minority Interest
114,337,400
95,763,800
84,735,800
32,727,300
29,038,200
Total Unusual Items Excluding Goodwill
-3,341,400
-4,106,500
-1,814,500
-45,668,700
-40,335,400
Total Unusual Items
-3,341,400
-4,106,500
-1,814,500
-45,668,700
-40,335,400
Normalized EBITDA
164,651,900
142,938,000
122,923,100
113,192,800
90,539,500
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-458,607.04
-533,113.28
-163,465.32
-10,960,316.79
-7,416,035.40
3/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade